APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sodium Iodohippurate[131I] Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sodium Iodohippurate[131I] Injection Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchSodium Iodohippurate[131I] Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Sodium Iodohippurate[131I] Injection Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Sodium Iodohippurate[131I] Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sodium Iodohippurate[131I] Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Sodium Iodohippurate[131I] Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sodium Iodohippurate[131I] Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sodium Iodohippurate[131I] Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sodium Iodohippurate[131I] Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sodium Iodohippurate[131I] Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sodium Iodohippurate[131I] Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sodium Iodohippurate[131I] Injection market include Hta Co., Ltd, Chengdu Gaotong Isotope Co.,Ltd. and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sodium Iodohippurate[131I] Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sodium Iodohippurate[131I] Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sodium Iodohippurate[131I] Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Iodohippurate[131I] Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Sodium Iodohippurate[131I] Injection Segment by Company

Hta Co., Ltd

Chengdu Gaotong Isotope Co.,Ltd.

Mallinckrodt

Sodium Iodohippurate[131I] Injection Segment by Type

370 MBq

37 MBq

185 MBq

111 MBq

Others

Sodium Iodohippurate[131I] Injection Segment by Application

Urology and Andrology Hospital

General Hospital

Sodium Iodohippurate[131I] Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sodium Iodohippurate[131I] Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sodium Iodohippurate[131I] Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sodium Iodohippurate[131I] Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Sodium Iodohippurate[131I] Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodohippurate[131I] Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodohippurate[131I] Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodohippurate[131I] Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sodium Iodohippurate[131I] Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sodium Iodohippurate[131I] Injection industry.

Chapter 3: Detailed analysis of Sodium Iodohippurate[131I] Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sodium Iodohippurate[131I] Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sodium Iodohippurate[131I] Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sodium Iodohippurate[131I] Injection Industry Trends Table 2. Sodium Iodohippurate[131I] Injection Industry Drivers Table 3. Sodium Iodohippurate[131I] Injection Industry Opportunities and Challenges Table 4. Sodium Iodohippurate[131I] Injection Industry Restraints Table 5. Global Sodium Iodohippurate[131I] Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sodium Iodohippurate[131I] Injection Revenue Share by Company (2021-2026) Table 7. Global Sodium Iodohippurate[131I] Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Company (2021-2026) Table 9. Global Sodium Iodohippurate[131I] Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sodium Iodohippurate[131I] Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sodium Iodohippurate[131I] Injection Key Company Manufacturing Base & Headquarters Table 12. Global Sodium Iodohippurate[131I] Injection Company, Product Type & Application Table 13. Global Sodium Iodohippurate[131I] Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sodium Iodohippurate[131I] Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 370 MBq Table 18. Significant Companies of 37 MBq Table 19. Significant Companies of 185 MBq Table 20. Significant Companies of 111 MBq Table 21. Significant Companies of Others Table 22. Global Sodium Iodohippurate[131I] Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Sodium Iodohippurate[131I] Injection Sales Volume by Type (2021-2026) & (k units) Table 24. Global Sodium Iodohippurate[131I] Injection Sales Volume by Type (2027-2032) & (k units) Table 25. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Type (2021-2026) Table 26. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Type (2027-2032) Table 27. Global Sodium Iodohippurate[131I] Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Sodium Iodohippurate[131I] Injection Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Sodium Iodohippurate[131I] Injection Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Type (2021-2026) Table 31. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Urology and Andrology Hospital Table 33. Significant Companies of General Hospital Table 34. Global Sodium Iodohippurate[131I] Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Sodium Iodohippurate[131I] Injection Sales Volume by Application (2021-2026) & (k units) Table 36. Global Sodium Iodohippurate[131I] Injection Sales Volume by Application (2027-2032) & (k units) Table 37. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Application (2021-2026) Table 38. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Application (2027-2032) Table 39. Global Sodium Iodohippurate[131I] Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sodium Iodohippurate[131I] Injection Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sodium Iodohippurate[131I] Injection Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Application (2021-2026) Table 43. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Application (2027-2032) Table 44. Global Sodium Iodohippurate[131I] Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Sodium Iodohippurate[131I] Injection Sales by Region (2021-2026) & (k units) Table 46. Global Sodium Iodohippurate[131I] Injection Sales Market Share by Region (2021-2026) Table 47. Global Sodium Iodohippurate[131I] Injection Sales by Region (2027-2032) & (k units) Table 48. Global Sodium Iodohippurate[131I] Injection Sales Market Share by Region (2027-2032) Table 49. Global Sodium Iodohippurate[131I] Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sodium Iodohippurate[131I] Injection Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Region (2021-2026) Table 52. Global Sodium Iodohippurate[131I] Injection Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Region (2027-2032) Table 54. Global Sodium Iodohippurate[131I] Injection Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Sodium Iodohippurate[131I] Injection Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Sodium Iodohippurate[131I] Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Sodium Iodohippurate[131I] Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sodium Iodohippurate[131I] Injection Sales by Country (2021-2026) & (k units) Table 59. Global Sodium Iodohippurate[131I] Injection Sales Market Share by Country (2021-2026) Table 60. Global Sodium Iodohippurate[131I] Injection Sales by Country (2027-2032) & (k units) Table 61. Global Sodium Iodohippurate[131I] Injection Sales Market Share by Country (2027-2032) Table 62. Global Sodium Iodohippurate[131I] Injection Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sodium Iodohippurate[131I] Injection Sales Value Market Share by Country (2021-2026) Table 64. Global Sodium Iodohippurate[131I] Injection Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sodium Iodohippurate[131I] Injection Sales Value Market Share by Country (2027-2032) Table 66. Hta Co., Ltd Company Information Table 67. Hta Co., Ltd Business Overview Table 68. Hta Co., Ltd Sodium Iodohippurate[131I] Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Hta Co., Ltd Sodium Iodohippurate[131I] Injection Product Portfolio Table 70. Hta Co., Ltd Recent Development Table 71. Chengdu Gaotong Isotope Co.,Ltd. Company Information Table 72. Chengdu Gaotong Isotope Co.,Ltd. Business Overview Table 73. Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodohippurate[131I] Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodohippurate[131I] Injection Product Portfolio Table 75. Chengdu Gaotong Isotope Co.,Ltd. Recent Development Table 76. Mallinckrodt Company Information Table 77. Mallinckrodt Business Overview Table 78. Mallinckrodt Sodium Iodohippurate[131I] Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Mallinckrodt Sodium Iodohippurate[131I] Injection Product Portfolio Table 80. Mallinckrodt Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Sodium Iodohippurate[131I] Injection Distributors List Table 84. Sodium Iodohippurate[131I] Injection Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Sodium Iodohippurate[131I] Injection Product Image Figure 2. Global Sodium Iodohippurate[131I] Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sodium Iodohippurate[131I] Injection Sales (2021-2032) & (k units) Figure 5. Global Sodium Iodohippurate[131I] Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sodium Iodohippurate[131I] Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 370 MBq Image Figure 10. 37 MBq Image Figure 11. 185 MBq Image Figure 12. 111 MBq Image Figure 13. Others Image Figure 14. Global Sodium Iodohippurate[131I] Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Sodium Iodohippurate[131I] Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Type (2021-2032) Figure 17. Global Sodium Iodohippurate[131I] Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Sodium Iodohippurate[131I] Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Type (2021-2032) Figure 20. Urology and Andrology Hospital Image Figure 21. General Hospital Image Figure 22. Global Sodium Iodohippurate[131I] Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Sodium Iodohippurate[131I] Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Application (2021-2032) Figure 25. Global Sodium Iodohippurate[131I] Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sodium Iodohippurate[131I] Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Application (2021-2032) Figure 28. Global Sodium Iodohippurate[131I] Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Sodium Iodohippurate[131I] Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sodium Iodohippurate[131I] Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sodium Iodohippurate[131I] Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sodium Iodohippurate[131I] Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sodium Iodohippurate[131I] Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sodium Iodohippurate[131I] Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sodium Iodohippurate[131I] Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sodium Iodohippurate[131I] Injection Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sodium Iodohippurate[131I] Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sodium Iodohippurate[131I] Injection Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sodium Iodohippurate[131I] Injection Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 370 MBq
  • 37 MBq
  • 185 MBq
  • 111 MBq
  • Others
Applications
  • Urology and Andrology Hospital
  • General Hospital
Companies covered
  • Hta Co., Ltd
  • Chengdu Gaotong Isotope Co.,Ltd.
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  4. 1.2.2 Global Sodium Iodohippurate[131I] Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Sodium Iodohippurate[131I] Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sodium Iodohippurate[131I] Injection Market Dynamics
  1. 2.1 Sodium Iodohippurate[131I] Injection Industry Trends
  2. 2.2 Sodium Iodohippurate[131I] Injection Industry Drivers
  3. 2.3 Sodium Iodohippurate[131I] Injection Industry Opportunities and Challenges
  4. 2.4 Sodium Iodohippurate[131I] Injection Industry Restraints
3 Sodium Iodohippurate[131I] Injection Market by Company
  1. 3.1 Global Sodium Iodohippurate[131I] Injection Company Revenue Ranking in 2025
  2. 3.2 Global Sodium Iodohippurate[131I] Injection Revenue by Company (2021-2026)
  3. 3.3 Global Sodium Iodohippurate[131I] Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Sodium Iodohippurate[131I] Injection Average Price by Company (2021-2026)
  5. 3.5 Global Sodium Iodohippurate[131I] Injection Company Ranking (2024-2026)
  6. 3.6 Global Sodium Iodohippurate[131I] Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Sodium Iodohippurate[131I] Injection Company Product Type and Application
  8. 3.8 Global Sodium Iodohippurate[131I] Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sodium Iodohippurate[131I] Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sodium Iodohippurate[131I] Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sodium Iodohippurate[131I] Injection Market by Type
  1. 4.1 Sodium Iodohippurate[131I] Injection Type Introduction
  2. 4.1.1 370 MBq
  3. 4.1.2 37 MBq
  4. 4.1.3 185 MBq
  5. 4.1.4 111 MBq
  6. 4.1.5 Others
  7. 4.2 Global Sodium Iodohippurate[131I] Injection Sales Volume by Type
  8. 4.2.1 Global Sodium Iodohippurate[131I] Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Sodium Iodohippurate[131I] Injection Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Sodium Iodohippurate[131I] Injection Sales Value by Type
  12. 4.3.1 Global Sodium Iodohippurate[131I] Injection Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Sodium Iodohippurate[131I] Injection Sales Value by Type (2021-2032)
  14. 4.3.3 Global Sodium Iodohippurate[131I] Injection Sales Value Share by Type (2021-2032)
5 Sodium Iodohippurate[131I] Injection Market by Application
  1. 5.1 Sodium Iodohippurate[131I] Injection Application Introduction
  2. 5.1.1 Urology and Andrology Hospital
  3. 5.1.2 General Hospital
  4. 5.2 Global Sodium Iodohippurate[131I] Injection Sales Volume by Application
  5. 5.2.1 Global Sodium Iodohippurate[131I] Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sodium Iodohippurate[131I] Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sodium Iodohippurate[131I] Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sodium Iodohippurate[131I] Injection Sales Value by Application
  9. 5.3.1 Global Sodium Iodohippurate[131I] Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sodium Iodohippurate[131I] Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sodium Iodohippurate[131I] Injection Sales Value Share by Application (2021-2032)
6 Sodium Iodohippurate[131I] Injection Regional Sales and Value Analysis
  1. 6.1 Global Sodium Iodohippurate[131I] Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sodium Iodohippurate[131I] Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Sodium Iodohippurate[131I] Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Sodium Iodohippurate[131I] Injection Sales by Region (2027-2032)
  5. 6.3 Global Sodium Iodohippurate[131I] Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sodium Iodohippurate[131I] Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sodium Iodohippurate[131I] Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sodium Iodohippurate[131I] Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Sodium Iodohippurate[131I] Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  12. 6.6.2 North America Sodium Iodohippurate[131I] Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Sodium Iodohippurate[131I] Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sodium Iodohippurate[131I] Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  21. 6.9.2 South America Sodium Iodohippurate[131I] Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sodium Iodohippurate[131I] Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sodium Iodohippurate[131I] Injection Sales Value Share by Country, 2025 VS 2032
7 Sodium Iodohippurate[131I] Injection Country-level Sales and Value Analysis
  1. 7.1 Global Sodium Iodohippurate[131I] Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sodium Iodohippurate[131I] Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sodium Iodohippurate[131I] Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Sodium Iodohippurate[131I] Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Sodium Iodohippurate[131I] Injection Sales by Country (2027-2032)
  6. 7.4 Global Sodium Iodohippurate[131I] Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sodium Iodohippurate[131I] Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sodium Iodohippurate[131I] Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sodium Iodohippurate[131I] Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sodium Iodohippurate[131I] Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sodium Iodohippurate[131I] Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hta Co., Ltd
  2. 8.1.1 Hta Co., Ltd Company Information
  3. 8.1.2 Hta Co., Ltd Business Overview
  4. 8.1.3 Hta Co., Ltd Sodium Iodohippurate[131I] Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hta Co., Ltd Sodium Iodohippurate[131I] Injection Product Portfolio
  6. 8.1.5 Hta Co., Ltd Recent Developments
  7. 8.2 Chengdu Gaotong Isotope Co.,Ltd.
  8. 8.2.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
  9. 8.2.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
  10. 8.2.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodohippurate[131I] Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodohippurate[131I] Injection Product Portfolio
  12. 8.2.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Sodium Iodohippurate[131I] Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Sodium Iodohippurate[131I] Injection Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sodium Iodohippurate[131I] Injection Value Chain Analysis
  2. 9.1.1 Sodium Iodohippurate[131I] Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sodium Iodohippurate[131I] Injection Sales Mode & Process
  6. 9.2 Sodium Iodohippurate[131I] Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sodium Iodohippurate[131I] Injection Distributors
  9. 9.2.3 Sodium Iodohippurate[131I] Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst